A comprehensive review of glycocalyx investigation and therapeutic applications in sepsis and septic shock

1 Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020 Jan; 395(10219): 200-211. DOI: 10.1016/S0140-6736(19)32989-7 Search in Google Scholar

2 Giamarellos-Bourboulis EJ; European Sepsis Alliance (ESA); Zinkernagel AS; European Society of Clinical Microbiology and Infectious Diseases (ESCMID); De Robertis E; European Society of Anesthesiology and Intensive Care (ESAIC); et al. Sepsis, a call for inclusion in the work plan of the European Center for Disease Prevention and Control. Intensive Care Med. 2023 August; 49: 1138-1142. DOI: 10.1007/s00134-023-07127-3 Search in Google Scholar

3 Chakraborty RK, Burns B. Systemic Inflammatory Response Syndrome. StatPearls [Internet]. 2023 May. Search in Google Scholar

4 Lee HJ, Ko BS, Ryoo SM, Han E, Suh GJ, Choi SH, et al. Modified cardiovascular SOFA score in sepsis: development and internal and external validation. BMC Med. 2022 Dec; 20(1): 476. DOI: 10.1186/s12916-022-02694-6 Search in Google Scholar

5 Bagaswoto HP, Ardelia YP, Setianto BY. First 24-h Sardjito Cardiovascular Intensive Care (SCIENCE) admission risk score to predict mortality in cardiovascular intensive care unit (CICU). Indian Heart J. 2022 Nov-Dec; 74(6): 513-518. DOI: 10.1016/j. ihj.2022.11.002 Search in Google Scholar

6 Raveendran AV, Kumar A, Gangadharan S. Biomarkers and newer laboratory investigations in the diagnosis of sepsis. J R Coll Physicians Edinb. 2019 Sep; 49(3): 207-216. DOI: 10.4997/jrcpe.2019.308 Search in Google Scholar

7 Font MD, Thyagarajan B, Khanna AK. Sepsis and Septic Shock -Basics of diagnosis, pathophysiology and clinical decision making. Med Clin North Am. 2020 Jul; 104(4): 573-585. DOI: 10.1016/j. mcna.2020.02.011 Search in Google Scholar

8 Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. Crit Care. 2020 May; 24(1): 239. DOI: 10.1186/s13054-020-02950-2 Search in Google Scholar

9 Uchimido R, Schmidt EP, Shapiro NI. The glycocalyx: a novel diagnostic and therapeutic target in sepsis. Crit Care. 2019 Jan; 23(1): 16. DOI: 10.1186/s13054-018-2292-6 Search in Google Scholar

10 Foote CA, Soares RN, Ramirez-Perez FI, Ghiarone T, Aroor A, Manrique-Acevedo C, et al. Endothelial Glycocalyx. Compr Physiol. 2022 Aug; 12(4): 3781-3811. DOI: 10.1002/cphy.c210029 Search in Google Scholar

11 Dull RO, Hahn RG. The glycocalyx as a permeability barrier: basic science and clinical evidence. Crit Care. 2022 Sep; 26(1): 273. DOI: 10.1186/s13054-022-04154-2 Search in Google Scholar

12 Farrugia BL, Lord MS, Melrose J, Whitelock JM. The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies. J Histochem Cytochem. 2018 April; 66(4): 321-336. DOI: 10.1369/0022155417740881 Search in Google Scholar

13 Iba T, Levy JH. Derangement of the endothelial glycocalyx in sepsis. J Thromb Haemost. 2019 Feb; 17(2): 283-294. DOI: 10.1111/jth.14371 Search in Google Scholar

14 Martin JV, Liberati DM, Diebel LN. Excess sodium is deleterious on endothelial and glycocalyx barrier function: A microfluidic study. J Trauma Acute Care Surg. 2018 Jul; 85(1): 128-134. DOI: 10.1097/TA.0000000000001892 Search in Google Scholar

15 Cinelli MA, Do HT, Miley GP, Silverman RB. Inducible nitric oxide synthase: Regulation, structure, and inhibition. Med Res Rev. 2020 Jan; 40(1): 158-189. DOI: 10.1002/med.21599 Search in Google Scholar

16 Ince C, Mayeux PR, Nguyen T, Gomez H, Kellum JA, Ospina-Tascón GA, et al. THE ENDOTHELIUM IN SEPSIS. Shock. 2016 Mar; 45(3): 259-270. DOI: 10.1097/SHK.0000000000000473 Search in Google Scholar

17 Gabarin RS, Li M, Zimmel PA, Marshall JC, Li Y, Zhang H. Intracellular and Extracellular Lipopolysaccharide Signaling in Sepsis: Avenues for Novel Therapeutic Strategies. J Innate Immun. 2021; 13(6): 323-332. DOI: 10.1159/000515740 Search in Google Scholar

18 Suwarto S, Sasmono RT, Sinto R, Ibrahim E, Suryamin M. Association of Endothelial Glycocalyx and Tight and Adherens Junctions With Severity of Plasma Leakage in Dengue Infection. J Infect Dis. 2017 Mar; 215(6): 992-999. DOI: 10.1093/infdis/jix041 Search in Google Scholar

19 Yang X, Meegan JE, Jannaway M, Coleman DC, Yuan SY. A disintegrin and metalloproteinase 15-mediated glycocalyx shedding contributes to vascular leakage during inflammation. Cardiovasc Res. 2018 Nov; 114(13): 1752-1763. DOI: 10.1093/cvr/cvy167 Search in Google Scholar

20 Weinbaum S, Cancel LM, Fu BM, Tarbell JM. The Glycocalyx and Its Role in Vascular Physiology and Vascular Related Diseases. Cardiovasc Eng Technol. 2021 Sept; 12: 37-71. DOI: 10.1007/s13239-020-00485-9 Search in Google Scholar

21 Diebel LN, Liberati DM, Martin JV. Acute hyperglycemia increases sepsis related glycocalyx degradation and endothelial cellular injury: A microfluidic study. Am J Surg. 2019 June; 217(6): 1076-1082. DOI: 10.1016/j.amjsurg.2018.12.066 Search in Google Scholar

22 Li Z, Wu N, Wang J, Zhang Q. Roles of Endovascular Calyx Related Enzymes in Endothelial Dysfunction and Diabetic Vascular Complications. Front Pharmacol. 2020 Nov; 11: 590614. DOI: 10.3389/fphar.2020.590614 Search in Google Scholar

23 Haymet AB, Bartnikowski N, Wood ES, Vallely MP, McBride A, Yacoub S, et al. Studying the Endothelial Glycocalyx in vitro: What Is Missing? Front Cardiovasc Med. 2021 Apr; 8: 647086. DOI: 10.3389/fcvm.2021.647086 Search in Google Scholar

24 Okada H, Takemura G, Suzuki K, Oda K, Takada C, Hotta Y, et al. Three-dimensional ultrastructure of capillary endothelial glycocalyx under normal and experimental endotoxemic conditions. Crit Care. 2017 Oct; 21(1): 261. DOI: 10.1186/s13054-017-1841-8 Search in Google Scholar

25 Cerny V, Astapenko D, Burkovskiy I, Hyspler R, Ticha A, Trevors MA, et al. Glycocalyx in vivo measurement. Clin Hemorheol Microcirc. 2017; 67(3-4): 499-503. DOI: 10.3233/CH-179235 Search in Google Scholar

26 Kataoka H, Ushiyama A, Akimoto Y. Structural Behavior of the Endothelial Glycocalyx Is Associated With Pathophysiologic Status in Septic Mice. Anesth Analg. 2017 Sep; 125(3): 874-883. DOI: 10.1213/ANE.0000000000002057 Search in Google Scholar

27 Rovas A, Lukasz AH, Vink H, Urban M, Sackarnd J, Pavenstädt H, et al. Bedside analysis of the sublingual microvascular glycocalyx in the emergency room and intensive care unit - the GlycoNurse study. Scand J Trauma Resusc Emerg Med. 2018 Feb; 26(1): 16. DOI: 10.1186/s13049-018-0483-4 Search in Google Scholar

28 Valerio L, Peters RJ, Zwinderman AH, Pinto-Sietsma SJ. Reproducibility of sublingual microcirculation parameters obtained from sidestream darkfield imaging. PLoS One. 2019 Mar; 14(3): e0213175. DOI: 10.1371/journal.pone.0213175 Search in Google Scholar

29 Nelson A, Johansson J, Tydén J, Bodelsson M. Circulating syndecans during critical illness. APMIS. 2017 May; 125(5): 468-475. DOI: 10.1111/apm.12662 Search in Google Scholar

30 Smart L, Macdonald SPJ, Burrows S, Bosio E, Arendts G, Fatovich DM. Endothelial glycocalyx biomarkers increase in patients with infection during Emergency Department treatment. J Crit Care. 2017 Dec; 42: 304-309. DOI: 10.1016/j.jcrc.2017.07.001 Search in Google Scholar

31 Sun T, Wang Y, Wu X, Cai Y, Zhai T, Zhan Q. Prognostic Value of Syndecan-1 in the Prediction of Sepsis-Related Complications and Mortality: A Meta-Analysis. Front Public Health. 2022 Apr; 10: 870065. DOI: 10.3389/fpubh.2022.870065 Search in Google Scholar

32 Schmidt EP, Overdier KH, Sun X, Lin L, Liu X, Yang Y, et al. Urinary Glycosaminoglycans Predict Outcomes in Septic Shock and Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2016 Aug; 194(4): 439-449. DOI: 10.1164/rccm.201511-2281OC Search in Google Scholar

33 Cowman MK, Lee HG, Schwertfeger KL, McCarthy JB, Turley EA. The Content and Size of Hyaluronan in Biological Fluids and Tissues. Front Immunol. 2015 June; 6: 261. DOI: 10.3389/fimmu.2015.00261 Search in Google Scholar

34 Ikeda M, Matsumoto H, Ogura H, Hirose T, Shimizu K, Yamamoto K, et al. Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis. J Crit Care. 2018 Feb; 43: 48-53. DOI: 10.1016/j.jcrc.2017.07.049 Search in Google Scholar

35 Lukasz A, Hillgruber C, Oberleithner H, Kusche-Vihrog K, Pavenstädt H, Rovas A, et al. Endothelial glycocalyx breakdown is mediated by angiopoietin-2. Cardiovasc Res. 2017 May; 113(6): 671-680. DOI: 10.1093/cvr/cvx023 Search in Google Scholar

36 Wu Q, Xu WD, Huang AF. Role of angiopoietin-2 in inflammatory autoimmune diseases: A comprehensive review. Int Immunopharmacol. 2020 Mar; 80: 106223. DOI: 10.1016/j. intimp.2020.106223 Search in Google Scholar

37 Rathnakumar K, Savant S, Giri H, Ghosh A, Fisslthaler B, Fleming I, et al. Angiopoietin-2 mediates thrombin-induced monocyte adhesion and endothelial permeability. J Thromb Haemost. 2016 August;(14): 1655-1667. DOI: 10.1111/jth.13376 Search in Google Scholar

38 Becker BF, Jacob M, Leipert S, Salmon AH, Chappell D. Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases. Br J Clin Pharmacol. 2015 Sep; 80(3): 389-402. DOI: 10.1111/bcp.12629 Search in Google Scholar

39 Joffre J, Hellman J. Oxidative Stress and Endothelial Dysfunction in Sepsis and Acute Inflammation. Antioxid Redox Signal. 2021 Nov; 35(15): 1291-1307. DOI: 10.1089/ars.2021.0027 Search in Google Scholar

40 Delgadillo LF, Marsh GA, Waugh RE. Endothelial Glycocalyx Layer Properties and Its Ability to Limit Leukocyte Adhesion. Biophys J. 2020 Apr; 118(7): 1564-1575. DOI: 10.1016/j.bpj.2020.02.010 Search in Google Scholar

41 Mast AE. Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein. Arterioscler Thromb Vasc Biol. 2016 Jan; 36(1): 9-14. DOI: 10.1161/ATVBAHA.115.305996 Search in Google Scholar

42 Arnold K, Liao YE, Liu J. Potential Use of Anti-Inflammatory Synthetic Heparan Sulfate to Attenuate Liver Damage. Biomedicines. 2020 Nov; 8(11): 503. DOI: 10.3390/biomedicines8110503 Search in Google Scholar

43 Sungurlu S, Kuppy J, Balk RA. Role of Antithrombin III and Tissue Factor Pathway in the Pathogenesis of Sepsis. Crit Care Clin. 2020 Apr; 36(2): 255-265. DOI: 10.1016/j.ccc.2019.12.002 Search in Google Scholar

44 Ostrowski SR, Haase N, Müller RB, Møller MH, Pott FC, Perner A, et al. Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: a prospective study. Crit Care. 2015 Apr; 19(1): 191. DOI: 10.1186/s13054-015-0918-5 Search in Google Scholar

45 Dimitrievska S, Gui L, Weyers A, Lin T, Cai C, Wu W, et al. New Functional Tools for Antithrombogenic Activity Assessment of Live Surface Glycocalyx. Arterioscler Thromb Vasc Biol. 2016 Sep; 36(9): 1847-1853. DOI: 10.1161/ATVBAHA.116.308023 Search in Google Scholar

46 Graetz TJ, Hotchkiss RS. Sepsis: Preventing organ failure in sepsis -the search continues. Nat Rev Nephrol. 2017 Jan; 13(1): 5-6. DOI: 10.1038/nrneph.2016.171 Search in Google Scholar

47 Iba T, Levy JH. Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis. J Thromb Haemost. 2018 Feb; 16(2): 231-241. DOI: 10.1111/jth.13911 Search in Google Scholar

48 Proudfoot AEI, Johnson Z, Bonvin P, Handel TM. Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex System. Pharmaceuticals (Basel). 2017 Aug; 10(3): 70. DOI: 10.3390/ph10030070 Search in Google Scholar

49 Yang Y, Haeger SM, Suflita MA, Zhang F, Dailey KL, Colbert JF, et al. Fibroblast Growth Factor Signaling Mediates Pulmonary Endothelial Glycocalyx Reconstitution. Am J Respir Cell Mol Biol. 2017 Jun; 56(6): 727-737. DOI: 10.1165/rcmb.2016-0338OC Search in Google Scholar

50 Rizzo AN, Dudek SM. Endothelial Glycocalyx Repair: Building a Wall to Protect the Lung during Sepsis. Am J Respir Cell Mol Biol. 2017 Jun; 56(6): 687-688. DOI: 10.1165/rcmb.2017-0065ED Search in Google Scholar

51 Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017 Mar; 45(3): 486-552. Search in Google Scholar

52 Raghunathan K, Nailer P, Konoske R. What is the ideal crystalloid? Curr Opin Crit Care. 2015 Aug; 21(4): 309-314. DOI: 10.1097/MCC.0000000000000218 Search in Google Scholar

53 Zazzeron L, Gattinoni L, Caironi P. Role of albumin, starches and gelatins versus crystalloids in volume resuscitation of critically ill patients. Curr Opin Crit Care. 2016 Oct; 22(5): 428-436. DOI: 10.1097/MCC.0000000000000341 Search in Google Scholar

54 Chappell D, Bruegger D, Potzel J, Jacob M, Brettner F, Vogeser M, et al. Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx. Crit Care. 2014 Oct; 18(5): 538. DOI: 10.1186/s13054-014-0538-5 Search in Google Scholar

55 Wang G, Zhang H, Liu D, Wang X; Chinese Critical Ultrasound Study Group. Resuscitation fluids as drugs: targeting the endothelial glycocalyx. Chin Med J (Engl). 2020 Jan; 135(2): 137-144. DOI: 10.1097/CM9.0000000000001869 Search in Google Scholar

56 Uzawa K, Ushiyama A, Mitsuda S, Ando T, Sawa M, Miyao H, et al. The protective effect of hydroxyethyl starch solution on the glycocalyx layer in an acute hemorrhage mouse model. J Anesth. 2020 Feb; 34: 36-46. DOI: 10.1007/s00540-019-02692-8 Search in Google Scholar

57 Margraf A, Herter JM, Kühne K, Stadtmann A, Ermert T, Wenk M, et al. 6% Hydroxyethyl starch (HES 130/0.4) diminishes glycocalyx degradation and decreases vascular permeability during systemic and pulmonary inflammation in mice. Crit Care. 2018 May; 22(1): 111. DOI: 10.1186/s13054-017-1846-3 Search in Google Scholar

58 Corrêa TD, Rocha LL, Pessoa CM, Silva E, de Assuncao MS. Fluid therapy for septic shock resuscitation: which fluid should be used? Einstein (Sao Paulo). 2015 Jul-Sep; 13(3): 462-468. DOI: 10.1590/S1679-45082015RW3273 Search in Google Scholar

59 Aldecoa C, Llau JV, Nuvials X, Artigas A. Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: a review. Ann Intensive Care. 2020 Jun; 10(1): 85. DOI: 10.1186/s13613-020-00697-1 Search in Google Scholar

60 Zeng Y, Liu XH, Tarbell J, Fu B. Sphingosine 1-phosphate induced synthesis of glycocalyx on endothelial cells. Exp Cell Res. 2015 Nov; 339(1): 90-95. DOI: 10.1016/j.yexcr.2015.08.013 Search in Google Scholar

61 Chang R, Holcomb JB. Choice of Fluid Therapy in the Initial Management of Sepsis, Severe Sepsis, and Septic Shock. Shock. 2016 Jul; 46(1): 17-26. DOI: 10.1097/SHK.0000000000000577 Search in Google Scholar

62 Iba T, Maier CL, Helms J, Ferrer R, Thachil J, Levy JH. Managing sepsis and septic shock in an endothelial glycocalyx-friendly way: from the viewpoint of surviving sepsis campaign guidelines. Ann Intensive Care. 2024 Apr; 14(1): 64. DOI: 10.1186/s13613-024-01301-6 Search in Google Scholar

63 Cui N, Wang H, Long Y, Su L, Liu D. Dexamethasone Suppressed LPS-Induced Matrix Metalloproteinase and Its Effect on Endothelial Glycocalyx Shedding. Mediators Inflamm. 2015; 2015: 912726. DOI: 10.1155/2015/912726 Search in Google Scholar

64 Zhang X, Li X. The Role of Histones and Heparin in Sepsis: A Review. J Intensive Care Med. 2022 Mar; 37(3): 319-326. DOI: 10.1177/0885066621992320 Search in Google Scholar

65 Vagionas D, Papadakis DD, Politou M, Koutsoukou A, Vasileiadis I. Thromboinflammation in Sepsis and Heparin: A Review of Literature and Pathophysiology. In Vivo. 2022 Nov-Dec; 36(6): 2542-2557. DOI: 10.21873/invivo.12991 Search in Google Scholar

66 Song JW, Zullo JA, Liveris D, Dragovich M, Zhang XF, Goligorsky MS. Therapeutic Restoration of Endothelial Glycocalyx in Sepsis. J Pharmacol Exp Ther. 2017 Apr; 361(1): 115-121. DOI: 10.1124/jpet.116.239509 Search in Google Scholar

67 van Haare J, Kooi ME, van Teeffelen JW, Vink H, Slenter J, Cobelens H, et al. Metformin and sulodexide restore cardiac microvascular perfusion capacity in diet-induced obese rats. Cardiovasc Diabetol. 2021 Feb; 20(1): 53. DOI: 10.1186/s12933-021-01240-7 Search in Google Scholar

68 Ying J, Zhang C, Wang Y, Liu T, Yu Z, Wang K, et al. Sulodexide improves vascular permeability via glycocalyx remodelling in endothelial cells during sepsis. Front Immunol. 2023 Aug; 14: 1172892. DOI: 10.3389/fimmu.2023.1172892 Search in Google Scholar

69 Wang Q, Zhou X, Yang L, Luo M, Han L, Lu Y, et al. Gentiopicroside (GENT) protects against sepsis induced by lipopolysaccharide (LPS) through the NF-κB signaling pathway. Ann Transl Med. 2019 Dec; 7(23): 731. DOI: 10.21037/atm.2019.11.126 Search in Google Scholar

70 Ni J, Zhao Y, Su J, Liu Z, Fang S, Li L, et al. Toddalolactone Protects Lipopolysaccharide by Modulating HMGB1-NF-κB Translocation. Front Pharmacol. 2020 Feb; 11: 109. DOI: 10.3389/fphar.2020.00109 Search in Google Scholar